Cargando…

Astrocytic APOE4 removal confers cerebrovascular protection despite increased cerebral amyloid angiopathy

BACKGROUND: Alzheimer Disease (AD) and cerebral amyloid angiopathy (CAA) are both characterized by amyloid-β (Aβ) accumulation in the brain, although Aβ deposits mostly in the brain parenchyma in AD and in the cerebrovasculature in CAA. The presence of CAA can exacerbate clinical outcomes of AD pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiong, Monica, Wang, Chao, Gratuze, Maud, Saadi, Fareeha, Bao, Xin, Bosch, Megan E., Lee, Choonghee, Jiang, Hong, Serrano, Javier Remolina, Gonzales, Ernesto R., Kipnis, Michal, Holtzman, David M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018855/
https://www.ncbi.nlm.nih.gov/pubmed/36922879
http://dx.doi.org/10.1186/s13024-023-00610-x
_version_ 1784907898901495808
author Xiong, Monica
Wang, Chao
Gratuze, Maud
Saadi, Fareeha
Bao, Xin
Bosch, Megan E.
Lee, Choonghee
Jiang, Hong
Serrano, Javier Remolina
Gonzales, Ernesto R.
Kipnis, Michal
Holtzman, David M.
author_facet Xiong, Monica
Wang, Chao
Gratuze, Maud
Saadi, Fareeha
Bao, Xin
Bosch, Megan E.
Lee, Choonghee
Jiang, Hong
Serrano, Javier Remolina
Gonzales, Ernesto R.
Kipnis, Michal
Holtzman, David M.
author_sort Xiong, Monica
collection PubMed
description BACKGROUND: Alzheimer Disease (AD) and cerebral amyloid angiopathy (CAA) are both characterized by amyloid-β (Aβ) accumulation in the brain, although Aβ deposits mostly in the brain parenchyma in AD and in the cerebrovasculature in CAA. The presence of CAA can exacerbate clinical outcomes of AD patients by promoting spontaneous intracerebral hemorrhage and ischemia leading to CAA-associated cognitive decline. Genetically, AD and CAA share the ε4 allele of the apolipoprotein E (APOE) gene as the strongest genetic risk factor. Although tremendous efforts have focused on uncovering the role of APOE4 on parenchymal plaque pathogenesis in AD, mechanistic studies investigating the role of APOE4 on CAA are still lacking. Here, we addressed whether abolishing APOE4 generated by astrocytes, the major producers of APOE, is sufficient to ameliorate CAA and CAA-associated vessel damage. METHODS: We generated transgenic mice that deposited both CAA and plaques in which APOE4 expression can be selectively suppressed in astrocytes. At 2-months-of-age, a timepoint preceding CAA and plaque formation, APOE4 was removed from astrocytes of 5XFAD APOE4 knock-in mice. Mice were assessed at 10-months-of-age for Aβ plaque and CAA pathology, gliosis, and vascular integrity. RESULTS: Reducing the levels of APOE4 in astrocytes shifted the deposition of fibrillar Aβ from the brain parenchyma to the cerebrovasculature. However, despite increased CAA, astrocytic APOE4 removal reduced overall Aβ-mediated gliosis and also led to increased cerebrovascular integrity and function in vessels containing CAA. CONCLUSION: In a mouse model of CAA, the reduction of  APOE4 derived specifically from astrocytes, despite increased fibrillar Aβ deposition in the vasculature, is sufficient to reduce Aβ-mediated gliosis and cerebrovascular dysfunction. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13024-023-00610-x.
format Online
Article
Text
id pubmed-10018855
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-100188552023-03-17 Astrocytic APOE4 removal confers cerebrovascular protection despite increased cerebral amyloid angiopathy Xiong, Monica Wang, Chao Gratuze, Maud Saadi, Fareeha Bao, Xin Bosch, Megan E. Lee, Choonghee Jiang, Hong Serrano, Javier Remolina Gonzales, Ernesto R. Kipnis, Michal Holtzman, David M. Mol Neurodegener Research Article BACKGROUND: Alzheimer Disease (AD) and cerebral amyloid angiopathy (CAA) are both characterized by amyloid-β (Aβ) accumulation in the brain, although Aβ deposits mostly in the brain parenchyma in AD and in the cerebrovasculature in CAA. The presence of CAA can exacerbate clinical outcomes of AD patients by promoting spontaneous intracerebral hemorrhage and ischemia leading to CAA-associated cognitive decline. Genetically, AD and CAA share the ε4 allele of the apolipoprotein E (APOE) gene as the strongest genetic risk factor. Although tremendous efforts have focused on uncovering the role of APOE4 on parenchymal plaque pathogenesis in AD, mechanistic studies investigating the role of APOE4 on CAA are still lacking. Here, we addressed whether abolishing APOE4 generated by astrocytes, the major producers of APOE, is sufficient to ameliorate CAA and CAA-associated vessel damage. METHODS: We generated transgenic mice that deposited both CAA and plaques in which APOE4 expression can be selectively suppressed in astrocytes. At 2-months-of-age, a timepoint preceding CAA and plaque formation, APOE4 was removed from astrocytes of 5XFAD APOE4 knock-in mice. Mice were assessed at 10-months-of-age for Aβ plaque and CAA pathology, gliosis, and vascular integrity. RESULTS: Reducing the levels of APOE4 in astrocytes shifted the deposition of fibrillar Aβ from the brain parenchyma to the cerebrovasculature. However, despite increased CAA, astrocytic APOE4 removal reduced overall Aβ-mediated gliosis and also led to increased cerebrovascular integrity and function in vessels containing CAA. CONCLUSION: In a mouse model of CAA, the reduction of  APOE4 derived specifically from astrocytes, despite increased fibrillar Aβ deposition in the vasculature, is sufficient to reduce Aβ-mediated gliosis and cerebrovascular dysfunction. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13024-023-00610-x. BioMed Central 2023-03-16 /pmc/articles/PMC10018855/ /pubmed/36922879 http://dx.doi.org/10.1186/s13024-023-00610-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Xiong, Monica
Wang, Chao
Gratuze, Maud
Saadi, Fareeha
Bao, Xin
Bosch, Megan E.
Lee, Choonghee
Jiang, Hong
Serrano, Javier Remolina
Gonzales, Ernesto R.
Kipnis, Michal
Holtzman, David M.
Astrocytic APOE4 removal confers cerebrovascular protection despite increased cerebral amyloid angiopathy
title Astrocytic APOE4 removal confers cerebrovascular protection despite increased cerebral amyloid angiopathy
title_full Astrocytic APOE4 removal confers cerebrovascular protection despite increased cerebral amyloid angiopathy
title_fullStr Astrocytic APOE4 removal confers cerebrovascular protection despite increased cerebral amyloid angiopathy
title_full_unstemmed Astrocytic APOE4 removal confers cerebrovascular protection despite increased cerebral amyloid angiopathy
title_short Astrocytic APOE4 removal confers cerebrovascular protection despite increased cerebral amyloid angiopathy
title_sort astrocytic apoe4 removal confers cerebrovascular protection despite increased cerebral amyloid angiopathy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018855/
https://www.ncbi.nlm.nih.gov/pubmed/36922879
http://dx.doi.org/10.1186/s13024-023-00610-x
work_keys_str_mv AT xiongmonica astrocyticapoe4removalconferscerebrovascularprotectiondespiteincreasedcerebralamyloidangiopathy
AT wangchao astrocyticapoe4removalconferscerebrovascularprotectiondespiteincreasedcerebralamyloidangiopathy
AT gratuzemaud astrocyticapoe4removalconferscerebrovascularprotectiondespiteincreasedcerebralamyloidangiopathy
AT saadifareeha astrocyticapoe4removalconferscerebrovascularprotectiondespiteincreasedcerebralamyloidangiopathy
AT baoxin astrocyticapoe4removalconferscerebrovascularprotectiondespiteincreasedcerebralamyloidangiopathy
AT boschmegane astrocyticapoe4removalconferscerebrovascularprotectiondespiteincreasedcerebralamyloidangiopathy
AT leechoonghee astrocyticapoe4removalconferscerebrovascularprotectiondespiteincreasedcerebralamyloidangiopathy
AT jianghong astrocyticapoe4removalconferscerebrovascularprotectiondespiteincreasedcerebralamyloidangiopathy
AT serranojavierremolina astrocyticapoe4removalconferscerebrovascularprotectiondespiteincreasedcerebralamyloidangiopathy
AT gonzalesernestor astrocyticapoe4removalconferscerebrovascularprotectiondespiteincreasedcerebralamyloidangiopathy
AT kipnismichal astrocyticapoe4removalconferscerebrovascularprotectiondespiteincreasedcerebralamyloidangiopathy
AT holtzmandavidm astrocyticapoe4removalconferscerebrovascularprotectiondespiteincreasedcerebralamyloidangiopathy